Skin Analytics
Investment Stage – Early (2018)
Skin Analytics specialises in cancer screening for melanoma and non-melanoma skin cancers. The company invested heavily in technology with the potential to disrupt the process of diagnosis and management of skin cancer and has validated their proprietary technology in two large studies.
Skin Analytics
Investment Stage – Early (2018)
Skin Analytics specialises in cancer screening for melanoma and non-melanoma skin cancers. The company invested heavily in technology with the potential to disrupt the process of diagnosis and management of skin cancer and has validated their proprietary technology in two large studies.
